Coya Therapeutics, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the Annual Meeting of Stockholders held by Coya Therapeutics, Inc. on June 25, 2026. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC under the symbol "COYA."
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
The Annual Meeting addressed two primary matters:
- Election of Directors: Two Class I directors were elected for a three-year term.
- Secretary Wilbur Ross: Received 9,168,496 votes "For," 2,818,233 "Withheld," and 4,585,732 Broker Non-Votes.
- Dieter Weinand: Received 10,566,702 votes "For," 1,420,027 "Withheld," and 4,585,732 Broker Non-Votes.
- Ratification of Auditors: The appointment of Weaver and Tidwell, L.L.P. as the independent registered public accounting firm for the fiscal year ending December 31, 2026, was approved.
- Votes For: 16,545,887
- Votes Against: 22,661
- Abstain: 3,913
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, management outlook, specific risks, contingencies, or unusual items. The report is limited to the disclosure of voting outcomes.
Key Facts for Investor Verification
- Confirmation of the successful election of Wilbur Ross and Dieter Weinand to the Board of Directors.
- Verification of the ratification of Weaver and Tidwell, L.L.P. as the external auditor for the 2026 fiscal year.
- Review of the significant number of Broker Non-Votes (4,585,732) recorded for the director elections.
- Assessment of the "Withheld" vote count for Wilbur Ross, which was notably higher than for Dieter Weinand.